K562, Raji, and Ramos 2G6 (CRL-1923) cells were obtained from ATCC. Cell lines were cultured in RPMI supplemented with 10% FBS and 1% penicillin/streptomycin. For gene editing, 2 × 10
5 cells (K562) or 4 × 10
5 cells (Raji and Ramos) were pelleted by centrifugation and washed with PBS. AAV6 transductions were performed in 10 μL of serum-free RPMI media for 1 hour at 37°C in a 96-well U-bottom plate prior to electroporation, as previously described.
33 Cas9 RNPs were complexed by mixing 3000 ng
TrueCut Cas9 protein v2 (Thermo Fisher) with 60 pmol of gRNA (Synthego) for 15 minutes at room temperature.
Cells were then washed with PBS and resuspended in 20 μL of
SF (K562) or SG (Raji and Ramos) buffer (Lonza) and mixed with Cas9 RNPs. If appropriate, cells were also mixed with 1.4–2 μg of plasmid homology donors or 100 pmol phosphorothioate-modified ssODNs as previously described.
59 Electroporations were performed with the
4D-X Nucleofector (Lonza). K562 cells used pulse code FF-120, Raji cells used pulse code DS-104, and Ramos cells used pulse code CA-137.
J3-, A6-, or GFP-edited Raji and Ramos cells were expanded in culture. J3 and A6-edited cells were stained with anti-IgG-Fc antibody (BioLegend, clone M1310G05). Cells were sorted on a FACSAria II cell sorter based on membrane IgG expression (J3 and A6 editing) or GFP expression.
Rogers G.L., Huang C., Mathur A., Huang X., Chen H.Y., Stanten K., Morales H., Chang C.H., Kezirian E.J, & Cannon P.M. (2023). Reprogramming human B cells with custom heavy chain antibodies. Research Square.